Imexpharm

Imexpharm Market capitalization

The The market capitalization of Imexpharm (IMP.VN) as of Oct 27, 2026 is 8.22 T VND. In the previous year, The market capitalization was 8.22 T VND — a change of 0.00% (lower).

Market capitalization

8.22 TVND

YoY

0.00%

Last updated:

In 2025, Imexpharm's market cap stood at 8.22 T VND, a 0.00% increase from the 8.22 T VND market cap in the previous year.

The Imexpharm Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
8.22 T VND
Jan 1, 2019
8.22 T VND
Jan 1, 2020
8.22 T VND
Jan 1, 2021
8.22 T VND
Jan 1, 2022
8.22 T VND
Jan 1, 2023
8.22 T VND
Jan 1, 2024
8.22 T VND
Jan 1, 2025
8.22 T VND
The Imexpharm Market capitalization history
YEARMarket capitalizationYoY
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND0.00%
8.22 TVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Imexpharm's Market Capitalization

Imexpharm's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Imexpharm's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Imexpharm's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Imexpharm’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Imexpharm stock

The market capitalization of Imexpharm is 8.22 T VND in 2025.

The market capitalization of Imexpharm changed from 8.22 T VND to 8.22 T VND, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's VND, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' VND varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Imexpharm with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Imexpharm

All Key Metrics — Imexpharm